These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 1941824)
41. Anti-neutrophil cytoplasm antibodies in patients with ACR criteria for polyarteritis nodosa: help for systemic vasculitis classification? Baranger TA; Audrain MA; Testa A; Besnier D; Guillevin L; Esnault VL Autoimmunity; 1995; 20(1):33-7. PubMed ID: 7578859 [TBL] [Abstract][Full Text] [Related]
42. Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Savage CO; Pottinger BE; Gaskin G; Lockwood CM; Pusey CD; Pearson JD Clin Exp Immunol; 1991 Jul; 85(1):14-9. PubMed ID: 2070557 [TBL] [Abstract][Full Text] [Related]
43. [Rapidly progressing glomerulonephritis with antibodies against cytoplasm of neutrophilic leukocytes]. Tesar V; Zabka J; Stejskalová A; Bartůnková J; Jelínková E; Rychlík I; Mokrejsová M Cas Lek Cesk; 1992 Aug; 131(15):462-7. PubMed ID: 1423454 [TBL] [Abstract][Full Text] [Related]
44. Immune markers in vasculitis. Gaskin G; Savage CO Br J Hosp Med; 1991 Aug; 46(2):104-6. PubMed ID: 1912960 [TBL] [Abstract][Full Text] [Related]
45. Anticardiolipin and antineutrophil antibodies in giant cell arteritis. McHugh NJ; James IE; Plant GT J Rheumatol; 1990 Jul; 17(7):916-22. PubMed ID: 1698985 [TBL] [Abstract][Full Text] [Related]
46. Autoantibodies in systemic vasculitis. Savige JA; Gallicchio M; Chang L; Parkin JD Aust N Z J Med; 1991 Aug; 21(4):433-7. PubMed ID: 1659359 [TBL] [Abstract][Full Text] [Related]
47. von Willebrand factor antigen as an acute phase reactant and marker of endothelial cell injury in connective tissue diseases: a comparison with CRP, rheumatoid factor, and erythrocyte sedimentation rate. Blann AD Z Rheumatol; 1991; 50(5):320-2. PubMed ID: 1723232 [TBL] [Abstract][Full Text] [Related]
48. Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Egner W; Chapel HM Clin Exp Immunol; 1990 Nov; 82(2):244-9. PubMed ID: 1978703 [TBL] [Abstract][Full Text] [Related]
49. The autoimmune basis of ANCA positive systemic vasculitis. Oliveira DB; Lockwood CM Ann Med Interne (Paris); 1992; 143(6):396-8. PubMed ID: 1295393 [No Abstract] [Full Text] [Related]
50. Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Rossi F; Jayne DR; Lockwood CM; Kazatchkine MD Clin Exp Immunol; 1991 Feb; 83(2):298-303. PubMed ID: 1993362 [TBL] [Abstract][Full Text] [Related]
52. von Willebrand factor antigen compared with other factors in vasculitic syndromes. Ateş E; Bakkaloğlu A; Saatçi U; Söylemezoğlu O Arch Dis Child; 1994 Jan; 70(1):40-3. PubMed ID: 7906508 [TBL] [Abstract][Full Text] [Related]
53. The relationship between von Willebrand factor antigen and fibronectin in human plasma, endothelial cells and fibroblasts in culture. Giddings JC; Hogg S; Legg IR; Hughes IA Thromb Res; 1986 Nov; 44(3):291-301. PubMed ID: 3541279 [TBL] [Abstract][Full Text] [Related]
54. Antineutrophil cytoplasmic antibodies (ANCA): their role in diagnosis and pathogenesis of vasculitis. Field M Br J Rheumatol; 1991 Jun; 30(3):229-31. PubMed ID: 2049590 [No Abstract] [Full Text] [Related]
59. ANCA-associated vasculitis: is there a role for neutrophil apoptosis in autoimmunity? Harper L Expert Rev Clin Immunol; 2006 Mar; 2(2):237-44. PubMed ID: 20477074 [TBL] [Abstract][Full Text] [Related]
60. Antineutrophil cytoplasmic auto-antibodies in the diagnosis and management of vasculitis. Ress S S Afr Med J; 1989 Jan; 75(2):41. PubMed ID: 2913677 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]